Fergus Tomás Rocha de Oliveira

ORCID: 0000-0001-6869-9709
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Cancer and Skin Lesions
  • Breast Cancer Treatment Studies
  • Breast Lesions and Carcinomas
  • BRCA gene mutations in cancer
  • Male Breast Health Studies
  • Cancer Diagnosis and Treatment
  • PARP inhibition in cancer therapy
  • COVID-19 Pandemic Impacts
  • Education during COVID-19 pandemic
  • COVID-19 epidemiological studies
  • DNA Repair Mechanisms
  • Nonmelanoma Skin Cancer Studies
  • Tumors and Oncological Cases
  • Ear and Head Tumors
  • Multiple and Secondary Primary Cancers
  • Genital Health and Disease
  • Cancer Cells and Metastasis
  • Advanced Breast Cancer Therapies
  • Salivary Gland Tumors Diagnosis and Treatment

Universidade Estadual do Piau
2020-2023

Occult breast cancer (OBC) is characterized by metastatic presentation of undetectable tumor on imaging exams. OBC a rare disease (accounting for 0.3% to 1.0% all cancers) that represents major diagnostic challenge. The aim this study was report case with primary multiple cutaneous metastases subsequent emergence bone metastasis. A 70-year female patient had lesions in the left cervical region, breast, axillary subscapular three chirodactylus right hand and hand. Imaging tests (mammogram,...

10.11604/pamj.2021.40.23.31009 article EN cc-by Pan African Medical Journal 2021-01-01

Introduction Triple-negative breast cancer (TNBC) is a molecular subtype in which estrogen (ER)/progesterone receptor (PR) and human epidermal growth 2 (HER2) expression does not occur. The objective of this study was to analyze the impact pathologic complete response (pCR) after neoadjuvant chemotherapy on prognosis triple-negative patients. Methods This cohort conducted private-sector oncology clinic located city Teresina, Brazil. Medical charts 532 patients treated from 2007 2020 were...

10.7759/cureus.37396 article EN Cureus 2023-04-10

SUMMARY OBJECTIVE: Triple-negative breast cancer (TNBC) is characterized by lack of estrogen receptor, progesterone and human epidermal growth factor receptor 2 (HER2) expression accounts for 15–20% all cancers. This study aims to analyze prognostic factors related a reduction in overall survival (OS), disease-free (DFS), risk mortality recurrence TNBC. METHODS: retrospective observational cohort study. Medical records 532 patients with diagnosed from 2007 2020 were analyzed. Of these...

10.1590/1806-9282.20210249 article EN Revista da Associação Médica Brasileira 2021-07-01

Abstract Introduction: Male breast cancer (MBC) is a rare disease that accounts for 1% of cancers. The Oncotype DX test (a genomic signature assesses the expression 21 genes to estimate recurrence score [RS]) has been widely used in MBC select patients adjuvant chemotherapy. Objective: To describe 5 cases which nomogram was predict probability having high and need perform signature. Materials methods: Case series study five with treated between 2007 2020 at institution Teresina (Brazil) were...

10.15446/cr.v9n2.97697 article EN cc-by Case reports 2023-10-20

A COVID-19 é uma doença causada pela nova cepa viral da Família Coronaviridae (Sars-Cov-2), que surgiu na província de Hubei, China, em Dezembro 2019, e vem se disseminando rapidamente pelo mundo desde então. Assim, frente à importância infecção Sars-Cov-2 para o atual cenário mundial, também reflete no Piauí, devido relevância dados epidemiológicos estabelecimento políticas Saúde Pública mais efetivas, este estudo objetivou analisar a evolução epidemiológica dos casos estado do Piauí 2...

10.33448/rsd-v9i8.5777 article PT Research Society and Development 2020-07-09

Triple-negative breast cancer (TNBC) is an uncommon molecular subtype (representing 15%–20% of cancers) characterized by the non-expression estrogen receptor, progesterone and human epidermal growth receptor factor 2. More aggressive lethal, TNBC often associated with pathogenic variants in BRCA1/2 genes. This study aimed to describe a series seven cases patients All were female under 50 years age at diagnosis. Four them presented family history and/or other neoplasms. The predominant...

10.29289/2594539420210032 article EN Mastology 2021-01-01

Introduction: Occult breast cancer (OBC) is defined as a metastatic carcinoma that occurs mainly in the axillary lymph nodes, derived from primary malignant tumor undetectable by clinical and radiological analyses. OBC rare disease accounting for 0.3%–1.0% of all cancers, which more commonly at age around 55 years. The represents event (especially with manifestation systemic metastases) major diagnostic challenge. Thus, aim this study was to report case cutaneous metastases subsequent...

10.29289/259453942021v31s2078 article EN Mastology 2021-01-01

Introduction: Metaplastic breast carcinoma (MBC) is understood as a heterogeneous group of malignant tumors, which exhibits the transformation part or its entire glandular carcinomatous component into nonglandular by means epithelial and mixed mesenchymal differentiation. The MBC rare aggressive cancer, accounting for approximately 1% all tumors that have worse prognosis. aim this study was to describe four cases MBC, analyzing progression patients in mean follow-up 25 months (11–43 months)....

10.29289/259453942021v31s2075 article EN Mastology 2021-01-01

Introduction: Male breast cancer (MBC) is a very rare disease, which accounts for approximately 1.0% of all cancers and around 0.17%–1.0% male malignancies, more common in the age group 60 years, 93.7% cases MBC are histologically classified as invasive carcinoma no special type (ICNS). Treatment (i.e., surgery, radiotherapy, chemotherapy, hormone therapy) prognosis similar to women. The aim this study was describe five analyze occurrence relapse follow-up 88 months (36–180 months). Case...

10.29289/259453942021v31s2079 article EN Mastology 2021-01-01
Coming Soon ...